SERPINE1 and esophageal squamous cell carcinoma: CAF responds to the chemotherapeutic drug cisplatin used against esophageal squamous cell carcinoma (ESCC), by secreting paracrine signaling molecule plasminogen activator inhibitor 1 (PAI-1).